CONVERTIBLE SUBORDINATED PROMISSORY NOTE MATURITY DATE FOURTH EXTENSION AGREEMENT
Exhibit 10.2
CONVERTIBLE SUBORDINATED PROMISSORY NOTE MATURITY DATE
Whereas, Bioject Medical Technologies Inc., an Oregon corporation (the “Company”), borrowed $91,104 from Life Sciences Opportunities Fund II, L.P., a Delaware Limited Partnership (the “Lender”), pursuant to that certain Convertible Subordinated Promissory Note, dated as of December 5, 2007 (the “Note”); and
Whereas, the Maturity Date of the Note was extended from May 15 2009 to July 15, 2009, pursuant to an Extension Agreement dated April 6, 2009, between the Company and the Lender; the Maturity Date of the Note was further extended from July 15, 2009 to August 15, 2009, pursuant to the Second Extension Agreement dated July 13, 2009, between the Company and the Lender; and the Maturity Date of the Note was further extended from August 15, 2009 to August 31, 2009, pursuant to the Third Extension Agreement dated August 14, 2009, between the Company and the Lender;
Whereas, no principal and interest have been paid to date on the Note; and
Whereas, the Company has requested that the Lender extend the Maturity Date of the Note and all principal and interest due thereon to September 15, 2009;
For good and valuable consideration, the Company and the Lender agree as follow:
The Maturity Date of the Note is hereby extended to September 15, 2009 and all principal and interest due and payable on the Note shall be due and payable on September 15, 2009 (the “Fourth Extension”). All of the other terms and conditions of the Note, the Convertible Note Purchase and Warrant Agreement between the Company and the Lender dated as of December 5, 2007, as amended as of December 19, 2007, the Warrant to purchase 12,147 shares of the Company’s Common Stock issued by the Company to the Lender on December 5, 2007 and the Registration Rights Agreement between the Company and the Lender dated as of December 5, 2007, shall remain in full force and effect and were not and are not amended in any manner by the Extension Agreement, the Second Extension Agreement, the Third Extension Agreement and this Fourth Extension Agreement.
Dated: August 31, 2009
| LIFE SCIENCES OPPORTUNITIES FUND II, L.P. | ||
| By: | /s/ Xx Xxxxxx | |
| Signet Healthcare Partners, LLC, General Partner | ||
| Xx Xxxxxx, Managing Director | ||
Bioject Medical Technologies, Inc.
| By: | /s/ Xxxxx Xxxxx | |
| Xxxxx Xxxxx | ||
| President and Chief Executive Officer |
